Aura Biosciences, Inc. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -58.76M-76.41M-86.92M
Depreciation and Depletion 0.83M0.83M1.20M1.30M1.22M
Share-based Compensation 0.74M2.31M6.41M8.77M11.72M
Gains from Investment Securities 0.02M0.52M21.21M1.50M1.50M
Cash from Operations -24.32M-32.41M-54.60M-63.85M-79.81M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.83M0.83M1.20M1.30M1.22M
Change in Working Capital
Change in Account Payables -1.72M1.05M0.34M-1.04M0.48M
Change in Accured Expenses -1.79M2.21M0.23M3.31M1.58M
Other Working Capital Changes 0.17M3.58M3.25M-3.58M3.90M
Investing Activities
Capital Expenditures 0.77M2.12M1.09M0.71M1.25M
Change in Acquisitions & Divestments 53.01M120.40M129.18M
Cash from Investing Activities -0.77M-2.12M-67.87M-113.96M68.82M
Financing Activities
Other financing activities -0.03M-0.01M
Cash from Financing Activities 10.04M166.26M95.63M97.29M1.59M
Additional items
Change in Cash -15.06M131.72M-26.84M-80.52M-9.39M
Free Cash Flow -25.09M-34.53M-55.70M-64.56M-81.06M
Net Cash Flow -15.06M131.72M-26.84M-80.52M-9.39M